MEDIFAST INC (MED) - Net Assets

Latest as of March 2026: $197.68 Million USD

Based on the latest financial reports, MEDIFAST INC (MED) has net assets worth $197.68 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($252.05 Million) and total liabilities ($54.37 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how tangible is MEDIFAST INC's equity to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric Value
Current Net Assets $197.68 Million
% of Total Assets 78.43%
Annual Growth Rate 13.12%
5-Year Change -1.76%
10-Year Change 107.17%
Growth Volatility 54.95

MEDIFAST INC - Net Assets Trend (1996–2025)

This chart illustrates how MEDIFAST INC's net assets have evolved over time, based on quarterly financial data. See defensive interval ratio of MEDIFAST INC to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for MEDIFAST INC (1996–2025)

The table below shows the annual net assets of MEDIFAST INC from 1996 to 2025. For live valuation and market cap data, see MED company net worth.

Year Net Assets Change
2025-12-31 $198.92 Million -5.33%
2024-12-31 $210.11 Million +4.28%
2023-12-31 $201.48 Million +29.95%
2022-12-31 $155.04 Million -23.43%
2021-12-31 $202.47 Million +28.76%
2020-12-31 $157.25 Million +50.00%
2019-12-31 $104.83 Million -3.92%
2018-12-31 $109.11 Million +0.48%
2017-12-31 $108.58 Million +13.09%
2016-12-31 $96.02 Million +8.39%
2015-12-31 $88.58 Million +10.08%
2014-12-31 $80.48 Million -18.23%
2013-12-31 $98.42 Million +8.40%
2012-12-31 $90.79 Million +23.68%
2011-12-31 $73.40 Million +2.01%
2010-12-31 $71.96 Million +35.94%
2009-12-31 $52.93 Million +38.66%
2008-12-31 $38.17 Million +17.75%
2007-12-31 $32.42 Million +15.10%
2006-12-31 $28.17 Million +27.91%
2005-12-31 $22.02 Million +14.66%
2004-12-31 $19.21 Million +12.47%
2003-12-31 $17.08 Million +206.15%
2002-12-31 $5.58 Million +119.78%
2001-12-31 $2.54 Million +109.75%
2000-12-31 $1.21 Million +668.08%
1999-12-31 $-213.00K -109.92%
1998-12-31 $2.15 Million +6.50%
1997-12-31 $2.02 Million -63.83%
1996-12-31 $5.57 Million --

Equity Component Analysis

This analysis shows how different components contribute to MEDIFAST INC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 15963300000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Retained Earnings $158.27 Million 79.56%
Common Stock $11.00K 0.01%
Other Comprehensive Income $234.00K 0.12%
Other Components $40.41 Million 20.31%
Total Equity $198.92 Million 100.00%

MEDIFAST INC Competitors by Market Cap

The table below lists competitors of MEDIFAST INC ranked by their market capitalization.

Company Market Cap
Vigo System SA
WAR:VGO
$122.79 Million
Satellos Bioscience Inc.
TO:MSCL
$122.81 Million
Avaco Co. Ltd
KQ:083930
$122.82 Million
Lalin Property Public Company Limited
BK:LALIN
$122.82 Million
Sun Yad Construction Co Ltd
TW:1316
$122.69 Million
Traphaco JSC
VN:TRA
$122.68 Million
Aurora World Corporation
KQ:039830
$122.68 Million
GENOR BIOPHARMA DL-00002
F:67N0
$122.67 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in MEDIFAST INC's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 210,109,000 to 198,920,000, a change of -11,189,000 (-5.3%).
  • Net loss of 18,672,000 reduced equity.
  • Dividend payments of 195,000 reduced retained earnings.
  • Share repurchases of 369,000 reduced equity.
  • Other comprehensive income increased equity by 54,000.
  • Other factors increased equity by 7,993,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income $-18.67 Million -9.39%
Dividends Paid $195.00K -0.1%
Share Repurchases $369.00K -0.19%
Other Comprehensive Income $54.00K +0.03%
Other Changes $7.99 Million +4.02%
Total Change $- -5.33%

Book Value vs Market Value Analysis

This analysis compares MEDIFAST INC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.61x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 8.54x to 0.61x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1996-12-31 $1.29 $11.04 x
1997-12-31 $0.47 $11.04 x
1998-12-31 $0.45 $11.04 x
1999-12-31 $-0.04 $11.04 x
2000-12-31 $0.16 $11.04 x
2001-12-31 $0.31 $11.04 x
2002-12-31 $0.64 $11.04 x
2003-12-31 $1.56 $11.04 x
2004-12-31 $1.55 $11.04 x
2005-12-31 $1.72 $11.04 x
2006-12-31 $2.09 $11.04 x
2007-12-31 $2.38 $11.04 x
2008-12-31 $2.66 $11.04 x
2009-12-31 $3.59 $11.04 x
2010-12-31 $4.94 $11.04 x
2011-12-31 $5.17 $11.04 x
2012-12-31 $6.61 $11.04 x
2013-12-31 $7.12 $11.04 x
2014-12-31 $6.30 $11.04 x
2015-12-31 $7.34 $11.04 x
2016-12-31 $8.04 $11.04 x
2017-12-31 $8.98 $11.04 x
2018-12-31 $9.03 $11.04 x
2019-12-31 $8.65 $11.04 x
2020-12-31 $13.27 $11.04 x
2021-12-31 $17.14 $11.04 x
2022-12-31 $13.75 $11.04 x
2023-12-31 $18.45 $11.04 x
2024-12-31 $19.17 $11.04 x
2025-12-31 $18.11 $11.04 x

Capital Efficiency Dashboard

This dashboard shows how efficiently MEDIFAST INC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -9.39%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -4.84%
  • • Asset Turnover: 1.50x
  • • Equity Multiplier: 1.29x
  • Recent ROE (-9.39%) is below the historical average (20.47%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1996 5.74% 1.94% 1.44x 2.05x $-237.40K
1997 -183.38% -25.74% 2.07x 3.44x $-3.90 Million
1998 -44.20% -5.97% 1.54x 4.82x $-1.16 Million
1999 0.00% -68.63% 2.20x 0.00x $-3.17 Million
2000 107.69% 33.43% 1.25x 2.58x $1.18 Million
2001 23.17% 11.71% 1.50x 1.32x $334.20K
2002 47.02% 21.25% 1.25x 1.77x $2.07 Million
2003 14.11% 9.50% 1.05x 1.42x $702.30K
2004 9.10% 6.39% 1.05x 1.35x $-173.60K
2005 12.38% 6.80% 1.31x 1.39x $524.90K
2006 18.04% 6.86% 2.01x 1.31x $2.27 Million
2007 11.84% 4.58% 1.92x 1.35x $595.00K
2008 14.24% 5.15% 2.07x 1.34x $1.62 Million
2009 22.60% 7.22% 2.58x 1.21x $6.67 Million
2010 0.03% 7.61% 0.00x 1.31x $-7.18 Million
2011 25.26% 6.22% 2.82x 1.44x $11.20 Million
2012 17.49% 4.45% 2.74x 1.43x $6.80 Million
2013 24.35% 6.72% 2.69x 1.35x $14.13 Million
2014 16.38% 4.62% 2.46x 1.44x $5.13 Million
2015 22.64% 7.35% 2.32x 1.32x $11.20 Million
2016 18.58% 6.50% 2.26x 1.26x $8.23 Million
2017 25.53% 9.19% 2.07x 1.34x $16.86 Million
2018 51.13% 11.14% 2.96x 1.55x $44.88 Million
2019 74.32% 10.92% 3.67x 1.86x $67.43 Million
2020 65.41% 11.00% 3.39x 1.76x $87.13 Million
2021 81.01% 10.75% 3.83x 1.97x $143.78 Million
2022 92.60% 8.98% 5.06x 2.04x $128.06 Million
2023 49.34% 9.27% 3.46x 1.54x $79.27 Million
2024 1.00% 0.35% 2.12x 1.35x $-18.92 Million
2025 -9.39% -4.84% 1.50x 1.29x $-38.56 Million

Industry Comparison

This section compares MEDIFAST INC's net assets metrics with peer companies in the Personal Services industry.

Industry Context

  • Industry: Personal Services
  • Average net assets among peers: $548,642,964
  • Average return on equity (ROE) among peers: -74.24%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
MEDIFAST INC (MED) $197.68 Million 5.74% 0.28x $122.76 Million
Andersen Group Inc. (ANDG) $177.50 Million 66.86% 1.08x $500.76 Million
Bright Horizons Family Solutions Inc (BFAM) $145.51 Million 13.75% 0.70x $3.38 Billion
Click Holdings Limited (CLIK) $15.46 Million 0.00% 0.17x $4.26 Million
Carriage Services Inc (CSV) $155.97 Million 12.37% 3.79x $600.84 Million
E-Home Household Service Holdings Ltd (EJH) $32.73 Million 17.26% 0.25x $5.50 Million
Smart Share Global Ltd ADR (EM) $2.73 Billion 3.21% 0.62x $253.44 Million
Frontdoor Inc (FTDR) $239.00 Million 98.33% 7.82x $4.74 Billion
H&R Block Inc (HRB) $1.44 Billion 33.27% 2.63x $4.35 Billion
Inspire Veterinary Partners, Inc. Class A Common Stock (IVP) $1.56 Million -913.20% 11.93x $4.05 Million

About MEDIFAST INC

NYSE:MED USA Personal Services
Market Cap
$122.76 Million
Market Cap Rank
#18497 Global
#4239 in USA
Share Price
$11.04
Change (1 day)
-1.87%
52-Week Range
$9.53 - $15.22
All Time High
$294.26
About

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothi… Read more